Shire plc (SHPG)
Income statement / Yearly
Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Revenues:
Product sales

14,448

10,885

6,099

5,830

4,757

4,252

3,844

3,128

2,693

2,754

2,170

Royalties and other revenues

711

510

316

191

176

241

283

328

292

245

247

Other revenues

-

-

-

-

-

32

29

14

21

22

18

Total revenues

15,160

11,396

6,416

6,022

4,934

4,527

4,158

3,471

3,007

3,022

2,436

Costs and expenses:
Cost of sales

4,700

3,816

969

979

670

585

551

463

388

408

320

Research and development

1,763

1,439

1,564

1,067

933

953

764

661

639

494

544

Selling, general and administrative

3,530

3,015

1,842

1,782

1,499

1,948

1,675

1,526

1,342

1,455

1,210

Amortization of acquired intangible assets

1,768

1,173

498

243

152

-

-

-

-

-

-

In-process R&D ("IPR&D") charge

-

-

-

-

-

-

-

-

-

263

1,866

Integration and acquisition costs

894

883

39

158

-134

13

0

8

10

10

1

Reorganization costs

47

121

97

180

88

0

24

34

12

0

0

Goodwill impairment charge

-

-

-

-

198

0

0

-

-

-

-

(Gain)/loss on sale of Oncology and product rights

0

16

14

88

15

18

-6

16

6

20

127

Total operating expenses

12,705

10,433

4,997

4,324

3,200

3,482

3,022

2,677

2,387

2,610

3,815

Operating income from continuing operations

2,455

962

1,419

1,698

1,733

1,045

1,135

794

620

412

-1,379

Interest income

9

18

4

24

2

3

1

2

1

25

50

Interest expense

578

469

41

30

38

38

39

35

39

139

70

Other (expense)/income, net

7

-25

3

8

-3

-2

18

7

60

-32

1

Receipt of break fee

-

-

-

1,635

-

0

-

-

-

-

-

Total other expense, net

-561

-476

-33

1,638

-

-

-18

-24

22

-146

-19

Income from continuing operations before income taxes and equity in earnings of equity method investees

1,893

486

1,385

3,336

1,693

1,007

1,117

769

643

265

-1,398

Income taxes

-2,357

-126

46

56

277

203

236

182

138

98

55

Equity in earnings/(losses) of equity method investees, net of taxes

2

-8

-2

2

3

1

2

1

-0

2

1

Income from continuing operations, net of taxes

4,253

603

1,337

3,282

1,419

805

882

-

503

170

-1,451

(Loss)/gain from discontinued operations, net of taxes

18

-276

-34

122

-754

-60

-17

-

-12

-17

0

Add: Net loss attributable to the noncontrolling interest in subsidiaries

-

-

-

-

-

-

-

-

-0

-3

0

Net income

4,271

327

1,303

3,405

665

745

865

588

491

156

-1,451

Earnings per Ordinary Share basic
Earnings from continuing operations (in usd per share)

4.69

0.78

2.27

5.59

2.57

1.45

1.60

-

0.93

0.32

-2.68

Earnings from discontinued operations (in usd per share)

0.02

-0.35

-0.06

0.20

-1.36

-0.10

-0.03

-

-0.02

-0.03

0.00

Earnings per Ordinary Share - basic (in usd per share)

4.71

0.43

2.21

5.81

1.20

1.34

1.56

1.07

0.90

0.28

-2.68

Earnings per Ordinary Share diluted
Earnings from continuing operations (in usd per share)

4.66

0.77

2.26

5.55

2.45

1.41

1.53

-

0.91

0.31

-2.68

Earnings from discontinued operations (in usd per share)

0.02

-0.35

-0.06

0.20

-1.27

-0.10

-0.03

-

-0.02

-0.03

0.00

Earnings per Ordinary Share - diluted (in usd per share)

4.68

0.42

2.20

5.76

1.17

1.30

1.50

1.05

0.89

0.28

-2.68

Cash dividends declared per ordinary share (in USD per share)

-

-

-

0.21

-

-

-

-

-

-

-

Cash dividends paid per ordinary share (in USD per share)

-

-

-

0.21

-

-

-

-

-

-

-

Weighted average number of shares:
Basic (in shares)

906

770

590

586

552

555

551

546

540

541

540

Diluted (in shares)

912

776

593

591

590

593

595

590

548

545

540

Income from continuing operations, net of taxes

-

-

-

-

-

-

-

-

504

173

-1,451

Loss from discontinued operations, net of taxes

-

-

-

-

-

-

-

-

-12

-17

0

Numerator for basic earnings per share

4,271

327

1,303

-

-

-

-

-

491

156

-1,451